Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 51 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 8298542

    Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia

    The Board of Regents of the University of Texas System · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  2. US 8299033

    Iodo-hexose compounds useful to treat cancer

    The Board of Regents of the University of Texas System · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  3. US 8283458

    VMP-like sequences of pathogenic Borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted

  4. US 8273746

    Methods involving aldose reductase inhibitors

    The Board of Regents of the University of Texas System · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  5. US 8273729

    Treatment of irritable bowel syndrome and related bowel disease

    The Board of Regents of the University of Texas System · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  6. US 8258163

    Small-molecule agonists for type-2 orexin receptor

    The Board of Regents of the University of Texas System · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted

  7. US 8252764

    Compositions and methods of use of targeting peptides against placenta and adipose tissues

    The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted

  8. US 8252836

    Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease

    The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted

  9. US 8252841

    Methods of inhibiting bacterial virulence and compounds relating thereto

    The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted

  10. US 8252807

    Methods of inhibiting the interaction between S100 and the receptor for advanced glycation end-products

    The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted

  11. US 8252574

    Pseudoinfectious flavivirus and uses thereof

    The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted

  12. US 8236279

    Bisaminoethanethiol-targeting ligand conjugates and compositions

    The Board of Regents of the University of Texas System · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted

  13. US 8236983

    Composition and method for the treatment of diseases affected by apoptosis

    The Board of Regents of the University of Texas System · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted

  14. US 8232068

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    The Board of Regents of the University of Texas System · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted

  15. US 8216614

    Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis

    The Board of Regents of the University of Texas System · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  16. US 8216593

    Parasite vaccine

    The Board of Regents of the University of Texas System · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  17. US 8211635

    P53 modulator and cancer target

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  18. US 8212007

    Expression and purification of HIP/PAP and uses therefor

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  19. US 8212104

    Model of experimentally induced chronic pain and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  20. US 8211649

    Methods of diagnosing and prognosing hodgkin's lymphoma

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  21. US 8211941

    Antagonists of the transient receptor potential vanilloid 1 and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  22. US 8206724

    Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia

    The Board of Regents of the University of Texas System · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted

  23. US 8202848

    Identification of micro-RNAS involved in neuromuscular synapse maintenance and regeneration

    The Board of Regents of the University of Texas System · Granted Jun 19, 2012 · Expires Jun 14, 2032

    granted

  24. US 8198322

    Apoptotic and anti-tumor activities of metallo-salens

    The Board of Regents of the University of Texas System · Granted Jun 12, 2012 · Expires Jun 7, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.